Concord Stock Analysis

CCM Stock  USD 1.33  0.01  0.75%   
The new indifference towards the small price fluctuations of Concord Medical Services could raise concerns from stakeholders as the firm is trading at a share price of 1.33 on 602.00 in volume. The company executives did not add any value to Concord Medical investors in January. However, most investors can still diversify their portfolios with Concord Medical Services to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.4. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Concord Medical partners.
Continue to Trending Equities.
The Concord Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Concord Medical is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Concord Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Concord Medical's ongoing operational relationships across important fundamental and technical indicators.

Concord Stock Analysis Notes

About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.8. Concord Medical Services last dividend was issued on the 23rd of December 2015. The entity had 11384:1000 split on the 16th of January 2014. Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people. For more info on Concord Medical Services please contact Jianyu Yang at 86 10 5903 6688 or go to

Concord Medical Services Upcoming and Recent Events

Earnings reports are used by Concord Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Concord Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report21st of October 2022
Next Fiscal Quarter End31st of December 2021

Concord Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Concord Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Concord Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Concord Medical Services specific information freely available to individual and institutional investors to make a timely investment decision.

Concord Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Concord Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Concord Medical Services backward and forwards among themselves. Concord Medical's institutional investor refers to the entity that pools money to purchase Concord Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Wells Fargo CompanyCommon Shares4.6 K25 K
Wells Fargo CompanyCommon Shares4.3 K17 K
Wedbush Securities Inc 1Common Shares10.7 K25 K
Wedbush Securities Inc 1Common Shares21.2 K48 K
Wedbush Securities Inc 1Common Shares21.4 K60 K
Wedbush Securities Inc 1Common Shares16.7 K59 K
Wedbush Securities Inc 1Common Shares14.2 K50 K
Note, although Concord Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Concord Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 58.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Concord Medical's market, we take the total number of its shares issued and multiply it by Concord Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Concord Profitablity

Concord Medical's profitability indicators refer to fundamental financial ratios that showcase Concord Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Concord Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Concord Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Concord Medical's profitability requires more research than a typical breakdown of Concord Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (0.68) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (1.19) %, which entails that for every $100 of revenue, it lost -0.01.

Management Efficiency

The entity has Return on Asset of (0.0526) % which means that on every $100 spent on asset, it lost $0.0526. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (0.2263) %, meaning that it generated no profit with money invested by stockholders. Concord Medical management efficiency ratios could be used to measure how well concord medical services manages its routine affairs as well as how well it operates its assets and liabilities.
Long Term Debt Total
2.2 B
Non Current Liabilities Total
6.4 B
Short Long Term Debt Total
2.7 B
Interest Expense
73.8 M
Total Operating Expenses
401.4 M

Technical Drivers

As of the 2nd of February, Concord Medical shows the Mean Deviation of 5.54, risk adjusted performance of 0.0221, and Downside Deviation of 7.32. Concord Medical Services technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for Concord Medical Services, which can be compared to its rivals. Please confirm Concord Medical Services jensen alpha, as well as the relationship between the potential upside and skewness to decide if Concord Medical Services is priced correctly, providing market reflects its regular price of 1.33 per share. Given that Concord Medical is a hitting penny stock territory we recommend to closely look at its total risk alpha.

Concord Medical Services Price Movement Analysis

The output start index for this execution was three with a total number of output elements of fifty-eight. The Simple Moving Average indicator is calculated by adding the closing price of Concord Medical for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Concord Medical Services short-term fluctuations and highlight longer-term trends or cycles.

Concord Medical Predictive Daily Indicators

Concord Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Concord Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Concord Medical Forecast Models

Concord Medical time-series forecasting models is one of many Concord Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Concord Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Concord Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Concord Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Concord shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Concord Medical. By using and applying Concord Stock analysis, traders can create a robust methodology for identifying Concord entry and exit points for their positions.
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people.

Current Concord Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Concord analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Concord analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Concord Medical Services current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Concord analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Concord stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Concord Medical Services, talking to its executives and customers, or listening to Concord conference calls.
Concord Analyst Advice Details

Concord Stock Analysis Indicators

Concord Medical Services stock analysis indicators help investors evaluate how Concord Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Concord Medical shares will generate the highest return on investment. By understating and applying Concord Medical stock analysis, traders can identify Concord Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow446.4 M
Common Stock Shares Outstanding43.7 M
Total Stockholder Equity-1.4 B
Total Cashflows From Investing Activities-566 M
Tax Provision-6.6 M
Property Plant And Equipment Net3.3 B
Retained Earnings-3.3 B
Cash And Short Term Investments157.4 M
Cash157.4 M
Accounts Payable102.5 M
Net Debt2.6 B
50 Day M A1.5242
Total Current Liabilities804.5 M
Other Operating Expenses944 M
Non Current Assets Total5.6 B
Non Currrent Assets Other250.6 M
Continue to Trending Equities. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Concord Stock analysis

When running Concord Medical Services price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
58.2 M
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Concord Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.